Tower Research Capital (TRC)’s Avita Medical RCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding RCEL
Tower Research Capital (TRC)'s RCEL Position: Q3 2026 in Review
Tower Research Capital (TRC) increased its Avita Medical (RCEL) stake by 511% in Q3 2026, buying an estimated $92.1K and bringing the position to 13,885 shares worth $163K. The position accounts for ﹤0.01% of the portfolio, ranked #2503.
Tower Research Capital (TRC) first reported a position in RCEL in Q2 2020 and has held it in 24 quarters since. 89 funds tracked by Wall St. Rank hold RCEL as of Q3 2026.
- Tower Research Capital (TRC) held 13,885 shares of Avita Medical worth $163K as of Q3 2026.
- Tower Research Capital (TRC) bought 11,612 Avita Medical shares in Q3 2026, an estimated $92.1K.
- Avita Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #2503 holding.
- Tower Research Capital (TRC) first reported a position in Avita Medical in Q2 2020 and has held it in 24 quarters since.
- 89 funds tracked by Wall St. Rank held Avita Medical as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.